CompletedNot Applicable

Pain Inflammation and Cannabis in HIV

United States35 participantsStarted 2022-10-28

Plain-language summary

This study will examine how medical cannabis use affects neuropathic pain, inflammation and adverse events in people living with HIV (PLWH) with neuropathic pain. The investigators will observe how varying ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD) in medical cannabis impact neuropathic pain, inflammation and adverse events.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓\>=18 years old

What they're measuring

Change in Pain Severity Score

Timeframe: At weekly intervals from Baseline to 14 weeks

Trial details

NCT IDNCT05554146

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-03

Results submitted2025-10-09

View on ClinicalTrials.gov More HIV Infections trials